Zeke Capital Advisors’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,742
Closed -$476K 563
2019
Q3
$476K Buy
+1,742
New +$476K 0.04% 367
2018
Q4
Sell
-572
Closed -$523K 612
2018
Q3
$523K Buy
572
+72
+14% +$65.8K 0.04% 392
2018
Q2
$366K Sell
500
-193
-28% -$141K 0.03% 362
2018
Q1
$1.1M Buy
693
+217
+46% +$346K 0.1% 173
2017
Q4
$427K Buy
+476
New +$427K 0.04% 315